Japan’s Takeda Pharma says full-year profit slid 9.5%
15:24 JST, May 11, 2022
TOKYO (Reuters) – Takeda Pharmaceutical Co said on Wednesday that 12-month operating profit slid 9.5% from the previous year.
Operating profit for Japan’s largest drugmaker in the year that ended on March 31 came in at 461 billion yen ($3.54 billion).
That compares with its own earlier estimate of 515 billion yen and a consensus forecast of 509 billion yen from a Refinitiv poll of 15 analysts.
The company estimated the current fiscal year’s operating profit will rise to 520 billion yen.
($1 = 130.3700 yen)
"News Services" POPULAR ARTICLE
-
FBI Identifies Thomas Matthew Crooks as ‘Subject Involved’ in Trump Rally Shooting
-
Donald Trump Whisked off Stage in Pennsylvania after Apparent Gunshots Rang Through the Crowd
-
Japanese Executive among 11 Arrested in Myanmar for Inflating Rice Prices
-
Japan’s Nikkei Reclaims 40,000 Level on Weak Yen, Foreign Buying (UPDATE 1)
-
U.S. President Joe Biden Drops Out of the 2024 Race after Disastrous Debate Inflamed Age Concerns
JN ACCESS RANKING